Trump to announce all 50 states joining Medicaid drug pricing model

President Donald Trump is set to announce on Friday that all 50 states will join a Medicaid drug pricing model, according to AP reporting. This "GENEROUS" model aims to provide most favored nation pricing to certain drugs within the Medicaid program, resulting in lower net prices for selected drugs compared to prices in other countries.

The Trump administration asserts that Medicaid will save billions on prescription drug costs due to the plan. However, experts question the veracity of these savings since the specifics of the deals are not publicly disclosed. The announcement arrives as voters weigh cost-of-living concerns ahead of the midterm elections in November.

In an effort to address affordability issues, Trump has negotiated deals with pharmaceutical companies to ensure that U.S. drug prices remain competitive with those in other affluent nations. Last year, Trump signed an executive order implementing a "Most Favored Nations" policy, committing the U.S. to pay the lowest drug prices worldwide.

An estimated $529 billion in savings over a decade could result from these deals with pharmaceutical companies. However, the true extent of these savings remains uncertain due to the lack of transparency surrounding the negotiations. Critics argue that the administration's claims lack transparency and that the longevity of these price cuts is uncertain, as they may revert once the Trump administration ends.